Rapid RV/LV vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Rapid RV/LV

by RapidAI

eMurmur Heart AI

by eMurmur

AI Verdict

Tool A, Rapid RV/LV, is designed for the rapid assessment of pulmonary embolism severity by analyzing CTPA scans to measure right and left ventricle ratios. In contrast, Tool B, eMurmur Heart AI, focuses on the automated analysis of heart and lung sounds from auscultation to detect murmurs and provide hemodynamic insights. While both serve cardiology and pulmonology, their distinct data inputs (imaging vs. auscultation) and specific clinical applications mean they address different diagnostic needs.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is rapid, objective assessment of pulmonary embolism severity directly from CTPA scans. This tool is ideal for emergency departments and critical care settings where quick, AI-powered measurement of RV/LV ratios is essential for guiding immediate treatment decisions and triaging patients with suspected PE.

View Rapid RV/LV →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if you require an AI-powered solution for automated heart and lung sound analysis across various care settings, including telehealth. This tool is best suited for routine screening, long-term monitoring of cardiac conditions, and remote consultations, providing objective data on murmurs and hemodynamic insights.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Rapid RV/LV	eMurmur Heart AI
Pricing	Contact vendor for pricing information.	Contact for quote
Deployment	Unknown	Web-based, Mobile App, API integration
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

Tool B (eMurmur Heart AI) offers a more versatile and accessible user experience with its mobile app and web portal, supporting live streaming and remote auscultation for telehealth workflows. This broad deployment and features for ongoing monitoring provide greater flexibility for various clinical settings compared to Tool A's focus on rapid, image-based assessment.

Clinical Value

Tie

Both tools are FDA-cleared and address critical clinical needs within cardiology. Tool A (Rapid RV/LV) provides rapid, objective assessment of pulmonary embolism severity from CTPA scans, which is crucial for timely intervention in a life-threatening condition. Tool B (eMurmur Heart AI) offers AI-powered analysis of heart and lung sounds for detecting murmurs and providing hemodynamic insights, valuable for screening and monitoring across diverse patient populations and care settings. Both demonstrate significant clinical utility in their respective domains.

Pricing & Value

Tie

Both Tool A (Rapid RV/LV) and Tool B (eMurmur Heart AI) require prospective customers to contact the vendor directly for pricing information. This lack of transparent pricing for either product makes it impossible to conduct a head-to-head comparison on this dimension or assess their relative value.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements. Tool A (Rapid RV/LV) provides on-premises or hybrid deployment options, which may suit institutions with specific data control requirements. Tool B (eMurmur Heart AI) offers cloud-based, web, and mobile app deployment, providing scalability and agility for cloud-native strategies.

Innovation

eMurmur Heart AI

While both tools are innovative, Tool B (eMurmur Heart AI) stands out for its application of AI to the historically subjective practice of auscultation, providing objective analysis of heart and lung sounds, hemodynamic insights, and hardware-neutral compatibility. Its emphasis on telehealth and remote auscultation capabilities represents a significant advancement in democratizing access to advanced diagnostics.

Support & Docs

Tie

The provided structured facts and general web searches do not offer specific details regarding the level of customer support, available documentation, training resources, or service agreements for either Rapid RV/LV or eMurmur Heart AI. Without this information, it is not possible to differentiate between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Rapid RV/LV	eMurmur Heart AI
Name	Rapid RV/LV	eMurmur Heart AI
Company	RapidAI (formerly iSchemaView)	CSD Labs
Description	FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.	FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights.
Primary Function	Automated measurement of right and left ventricle diameters and RV/LV ratio from CTPA scans for pulmonary embolism severity.	Automated analysis of heart and lung sounds for detecting murmurs and providing hemodynamic insights.
Key Feature Example	AI-powered analysis of CTPA images, rapid results (within minutes of scan).	Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), live streaming and remote auscultation.
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Internal Medicine, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and eMurmur Heart AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application for each AI tool?

Rapid RV/LV by RapidAI is designed for the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. eMurmur Heart AI by CSD Labs focuses on automated analysis of heart and lung sounds to detect murmurs and provide hemodynamic insights.

What type of patient data does each tool analyze?

Rapid RV/LV analyzes CTPA (Computed Tomography Pulmonary Angiography) scan images to measure ventricular diameters. eMurmur Heart AI analyzes heart and lung sounds, supporting digital stethoscopes, mobile apps, and web portals for data input.

What specific measurements or insights do these AI tools provide to clinicians?

Rapid RV/LV provides automated measurements of right and left ventricle diameters and calculates the RV/LV ratio from CTPA images, along with annotated images showing ventricular measurements. eMurmur Heart AI offers detection and classification of pathologic and innocent heart murmurs, and hemodynamic insights such as loudness ratios of S1, systole, S2, and diastole.

Do either of these tools support telehealth or remote patient monitoring?

eMurmur Heart AI explicitly supports live streaming and remote auscultation for telehealth, as well as recording, secure storage, and playback of auscultation data for monitoring. Rapid RV/LV's description focuses on rapid in-hospital assessment from CTPA scans and does not specify telehealth capabilities.